NVCR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.29

Margin Of Safety %

Put/Call OI Ratio

0.13

EPS Next Q Diff

-0.1

EPS Last/This Y

0.17

EPS This/Next Y

0.33

Price

11.71

Target Price

22.8

Analyst Recom

1.8

Performance Q

-30.86

Upside

-419.5%

Beta

1.09

Ticker: NVCR

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	NVCR	13.84	0.11	0.03	19023
2026-10-15	NVCR	14.39	0.11	64.33	19070
2026-10-16	NVCR	14.08	0.11	24.44	19075
2026-10-19	NVCR	14.9	0.11	0.00	18302
2026-10-20	NVCR	15.7	0.11	0.02	18365
2026-10-21	NVCR	15.59	0.11	0.06	18469
2026-10-22	NVCR	15.1	0.10	0.12	18666
2026-10-23	NVCR	14.66	0.10	0.12	18666
2026-10-26	NVCR	14.4	0.11	0.50	18679
2026-10-27	NVCR	14.62	0.13	1.43	20159
2026-10-28	NVCR	14.15	0.13	0.42	20154
2026-10-29	NVCR	13.13	0.13	4.03	20351
2026-10-30	NVCR	13.14	0.13	0.48	20384
2026-11-02	NVCR	13.19	0.13	0.08	20617
2026-11-03	NVCR	13.45	0.13	0.00	20611
2026-11-04	NVCR	14.6	0.13	0.25	20604
2026-11-05	NVCR	13.55	0.13	0.00	20519
2026-11-06	NVCR	13.27	0.13	0.00	20525
2026-11-09	NVCR	12.53	0.13	0.00	20529
2026-11-10	NVCR	11.8	0.13	1.19	20290
2026-11-11	NVCR	11.98	0.13	0.00	20284
2026-11-12	NVCR	11.72	0.13	1.80	20282
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	NVCR	13.84	28.8	-	-1.24
2026-10-15	NVCR	14.40	28.8	-	-1.24
2026-10-16	NVCR	14.08	28.8	-	-1.24
2026-10-19	NVCR	14.90	28.8	-	-1.24
2026-10-20	NVCR	14.90	28.8	-	-1.24
2026-10-21	NVCR	15.71	28.8	-	-1.24
2026-10-22	NVCR	15.10	28.8	-	-1.24
2026-10-23	NVCR	14.66	28.8	-	-1.24
2026-10-26	NVCR	14.40	28.8	-	-1.24
2026-10-27	NVCR	14.62	28.8	-	-1.24
2026-10-28	NVCR	14.16	28.8	-	-1.24
2026-10-29	NVCR	13.11	28.8	-	-1.24
2026-10-30	NVCR	13.14	28.8	-	-1.24
2026-11-02	NVCR	13.19	-9.7	-	-1.24
2026-11-03	NVCR	13.45	-9.7	-	-1.06
2026-11-04	NVCR	14.60	-9.7	-	-1.05
2026-11-05	NVCR	13.56	-9.7	-	-1.05
2026-11-06	NVCR	13.27	-9.7	-	-1.05
2026-11-09	NVCR	12.52	-9.7	-	-1.05
2026-11-10	NVCR	11.80	-9.7	-	-1.05
2026-11-11	NVCR	12.01	-9.7	-	-1.05
2026-11-12	NVCR	11.71	-9.7	-	-1.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	NVCR	-0.46	5.61	10.67
2026-10-15	NVCR	-0.46	5.61	10.67
2026-10-16	NVCR	-0.46	5.61	10.67
2026-10-19	NVCR	-0.46	5.70	10.67
2026-10-20	NVCR	-0.46	5.70	10.67
2026-10-21	NVCR	-0.46	5.70	10.67
2026-10-22	NVCR	-0.46	5.70	10.67
2026-10-23	NVCR	-0.46	5.70	10.67
2026-10-26	NVCR	-0.46	4.43	10.67
2026-10-27	NVCR	-0.46	4.43	12.25
2026-10-28	NVCR	-0.46	4.43	12.25
2026-10-29	NVCR	-0.46	4.43	12.25
2026-10-30	NVCR	-0.46	4.43	12.25
2026-11-02	NVCR	-0.46	4.42	12.20
2026-11-03	NVCR	-0.46	4.42	12.20
2026-11-05	NVCR	-0.47	4.42	12.20
2026-11-06	NVCR	-0.47	4.42	12.20
2026-11-09	NVCR	-0.47	6.18	12.20
2026-11-10	NVCR	-0.47	6.18	12.20
2026-11-11	NVCR	-0.47	6.18	12.29
2026-11-12	NVCR	-0.47	6.18	12.29
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.09

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.19

Insider Transactions

-0.47

Institutional Transactions

6.18

Beta

1.09

Average Sales Estimate Current Quarter

189

Average Sales Estimate Next Quarter

190

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.2

Max Drawdown 5-Year %

-91.6

Target Price

22.8

P/E

Forward P/E

PEG

P/S

1.89

P/B

3.91

P/Free Cash Flow

EPS

-1.07

Average EPS Est. Cur. Y

-1.05

EPS Next Y. (Est.)

-0.72

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-16.78

Relative Volume

0.83

Return on Equity vs Sector %

-61.1

Return on Equity vs Industry %

-45.6

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.2

EBIT Estimation

◆ NVCR Healthcare

$11.72

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

23/25

Volume

7/15

Valuation

12/20

TP/AR

1/10

Options

6/10

RSI

32.4

Range 1M

4.5%

Sup Dist

0.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

17/25

Growth

22/30

Estimates

2/20

Inst/Vol

6/15

Options

7/10

EPS Yr

13.6%

EPS NY

27.7%

52W%

16.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +94.5% upside

Quality

6/30

Valuation

16/30

Growth

18/25

Stability

7/10

LT Trend

4/5

Upside

+94.5%

Quality

NVCR — P/E HistoricalMedical Instruments & Supplies

NovoCure Limited

Sector: Healthcare

Industry: Medical Devices

Employees: 1605

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

NVCR

Latest News

—

Caricamento notizie per NVCR…

stock quote shares NVCR – NovoCure Limited Stock Price stock today

news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch NVCR – NovoCure Limited yahoo finance google finance

stock history NVCR – NovoCure Limited invest stock market

stock prices NVCR premarket after hours

ticker NVCR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVCR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y